Natsar Pharmaceuticals, Inc.

New Filing
CIK: 0002134002·Pharmaceuticals·DELAWARE·Filed: May 7, 2026
Total Offering

Indefinite

Amount Sold

$4,221,000

Investors

15

First Sale

Apr 23, 2026

Offering Details

Type
Equity, Tenant in Common
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Venu Raman

Company

Natsar Pharmaceuticals, Inc.

4624 TALL MAPLE CT.

ELLICOTT CITY, MD, 21043

410-948-2578

SEC Filing

0002134002-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free